Home | Careers | Contact Us | Location Map | Sign In
   
 
   
 
 
 
Home >> Medical Zone > Enivac HB
E-mail this page Print this page
ENIVAC HB
 
  • Zahid Hussain, Syed S Ali, Syed A Husain, Mohammad Raish, Deepika R Sharma, Premashis Kar Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India
    World J Gastroenterol 2005; 11(45): 7165-7168
  • Kunal Das, R.K. Gupta, V. Kumar, Sanjay Singh, P.Kar
    Association of HLA Phenotype with Primary Non-response to Recombinant Hepatitis B Vaccine: A Study from North India
    Tropical Gastroenterology, 204; 25:113-115
  • Arora NK, Ganguly S, Sharma D et al.
    Hepatitis B immunization in low birthweight infants: do they need an additional dose?
    Acta Pediatr 2002; 91: 995 – 1001.
  • Kunal Das, R. K. Gupta, B. K. Sharma, V. Kumar, S. Singh & Kar P.
    Evaluation of immunogenicity and reactogenicity of rDNA Hepatitis B Vaccine in subjects over the age of forty years.
    Oral Presentation in Indian Association for study of the liver. Pg. 24.
  • Zahid Hussain, S. Sohail Ali et al.
    Evaluation of immunogenicity and reactogenicity of Enivac HB (recombinant DNA Hepatitis B Vaccine) produced in India.
    Indian Journal of Gastroenterology. March 2004, Vol. 23(Suppl. 1).
  • Kunal Das, R. K. Gupta, V. Kumar, P. Kar. 
    Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.  
    World JGastroenterol 2003; 9(5):1132-1134.
  • Kunal Das, P. Kar, Sanjay Singh, V. Kumar & B. K. Sharma.
    HLA phenotype and response to a single booster dose in non-responders to hepatitis B vaccination among age group more than forty years in North Indians.
    Poster presentation in 11th asian-pacific congress of gastroentrology. 8th Asian pacific congress of digestive endoscopy, March 10-14, 2000, Hong Kong, China, Pg.B32. Abstract No.A87.
  • Swatee Bapat, Datta Joshi, S.S.Malik et al.
    Hepatitis B immunization in Adolescent Girls.
    Indian Pediatrics, Oct 2001, Vol. 38: 1160-1162.
  • Sethi GR, Sharma S, Sudha S and Rishi RK.
    Immunogenicity of Recombinant Hepatitis B Vaccine in thalassemic Children. Indian Pediatrics 1999; 36: 498-501.51. Sethi GR, Sharma S, Sudha S and Rishi RK. Immunogenicity of Recombinant Hepatitis B Vaccine in thalassemic Children.
    Indian Pediatrics 1999; 36: 498-501. 
  • Singh S and Sharma DR.
    Tolerability of a recombinant DNA Hepatitis B Vaccine - Result of Post-Marketing Surveillance.
    Journal of Communicable Diseases, 1999; 31(1): 53-55.
  • Jain A, Jandwani P, Kar P et al.
    A Multicentric evaluation of recombinant DNA Hepatitis B vaccine of Cuban origin.
    Tropical Gastroenterology 2000; 21(1): 14 -17
  • Kaur Harjeet, Mani A.
    Seroprotection following Enivac-HB, a recombinant hepatitis B Vaccine (Letter).
    Indian Journal of Gastroenterology; 2000; 19(1): 41.